These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23439592)

  • 21. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
    Ikeda T; Abe A; Yusu S; Nakamura K; Ishiguro H; Mera H; Yotsukura M; Yoshino H
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):602-7. PubMed ID: 16836706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of Positive Ventricular Late Potentials Differs in Postural Changes among Supine, Left, and Right Lateral Decubitus, and Prone and Sitting Positions in Brugada Syndrome.
    Yoshioka K; Amino M; Nakamura M; Kanda S; Kobayashi Y; Ikari Y; Shima M; Tanabe T
    Ann Noninvasive Electrocardiol; 2015 Sep; 20(5):488-97. PubMed ID: 25545662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors.
    Okamura H; Kamakura T; Morita H; Tokioka K; Nakajima I; Wada M; Ishibashi K; Miyamoto K; Noda T; Aiba T; Nishii N; Nagase S; Shimizu W; Yasuda S; Ogawa H; Kamakura S; Ito H; Ohe T; Kusano KF
    Circ J; 2015; 79(2):310-7. PubMed ID: 25428522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian variation of late potentials in idiopathic ventricular fibrillation associated with J waves: insights into alternative pathophysiology and risk stratification.
    Abe A; Ikeda T; Tsukada T; Ishiguro H; Miwa Y; Miyakoshi M; Mera H; Yusu S; Yoshino H
    Heart Rhythm; 2010 May; 7(5):675-82. PubMed ID: 20189495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tpeak-Tend interval and risk of cardiac events in patients with Brugada syndrome].
    Wang JF; Shan QJ; Yang B; Chen ML; Zou JG; Chen C; Xu DJ; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):629-32. PubMed ID: 17961428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome.
    Morita H; Kusano KF; Miura D; Nagase S; Nakamura K; Morita ST; Ohe T; Zipes DP; Wu J
    Circulation; 2008 Oct; 118(17):1697-704. PubMed ID: 18838563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-domain T-wave alternans is strongly associated with a history of ventricular fibrillation in patients with Brugada syndrome.
    Uchimura-Makita Y; Nakano Y; Tokuyama T; Fujiwara M; Watanabe Y; Sairaku A; Kawazoe H; Matsumura H; Oda N; Ikanaga H; Motoda C; Kajihara K; Oda N; Verrier RL; Kihara Y
    J Cardiovasc Electrophysiol; 2014 Sep; 25(9):1021-1027. PubMed ID: 24761970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indication and prognostic significance of programmed ventricular stimulation in asymptomatic patients with Brugada syndrome.
    Asada S; Morita H; Watanabe A; Nakagawa K; Nagase S; Miyamoto M; Morimoto Y; Kawada S; Nishii N; Ito H
    Europace; 2020 Jun; 22(6):972-979. PubMed ID: 32167564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis.
    Hiramatsu S; Maruyama T; Ito H; Shimoda S; Kaji Y; Harada M
    Int Heart J; 2005 Nov; 46(6):1033-40. PubMed ID: 16394599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of site-specific late potentials using a novel Holter signal-averaged electrocardiography in patients with Brugada syndrome.
    Takahashi H; Takagi M; Yoshio T; Yoh M; Shiojima I
    Heart Rhythm; 2022 Oct; 19(10):1650-1658. PubMed ID: 35562054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of fever-induced Brugada syndrome.
    Mizusawa Y; Morita H; Adler A; Havakuk O; Thollet A; Maury P; Wang DW; Hong K; Gandjbakhch E; Sacher F; Hu D; Amin AS; Lahrouchi N; Tan HL; Antzelevitch C; Probst V; Viskin S; Wilde AA
    Heart Rhythm; 2016 Jul; 13(7):1515-20. PubMed ID: 27033637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Utility of Exercise Testing in Risk Stratification of Asymptomatic Patients With Type 1 Brugada Pattern.
    Subramanian M; Prabhu MA; Harikrishnan MS; Shekhar SS; Pai PG; Natarajan K
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):677-683. PubMed ID: 28316113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of spontaneous type I ECG pattern, syncope, and other risk markers in sudden cardiac arrest survivors with Brugada syndrome.
    Leong KMW; Ng FS; Jones S; Chow JJ; Qureshi N; Koa-Wing M; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Lim PB; Peters NS; Kanagaratnam P; Varnava AM
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):257-264. PubMed ID: 30569504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of T-wave alternans during the morning in the summer for the risk stratification of patients with Brugada syndrome.
    Sakamoto S; Takagi M; Kakihara J; Hayashi Y; Doi A; Sugioka K; Yoshiyama M
    Heart Vessels; 2017 Mar; 32(3):341-351. PubMed ID: 27480879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial electrophysiological abnormality in patients with Brugada syndrome assessed by P-wave signal-averaged ECG and programmed atrial stimulation.
    Yamada T; Watanabe I; Okumura Y; Takagi Y; Okubo K; Hashimoto K; Shindo A; Nakai T; Kasamaki Y; Saito S
    Circ J; 2006 Dec; 70(12):1574-9. PubMed ID: 17127802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolongation of LAS40 (duration of the low amplitude electric potential component (<40 microV) of the terminal portion of the QRS) induced by isoproterenol in 11 patients with Brugada syndrome.
    Takagi A; Nakazawa K; Sakurai T; Nanke T; Miyake F
    Circ J; 2002 Dec; 66(12):1101-4. PubMed ID: 12499613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.
    Nagayama T; Nagase S; Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Noda T; Aiba T; Takaki H; Sugimachi M; Shimizu W; Noguchi T; Yasuda S; Kamakura S; Kusano K
    Circ J; 2019 Feb; 83(3):532-539. PubMed ID: 30643106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility evaluation of long-term use of beta-blockers and calcium antagonists in patients with Brugada syndrome.
    Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Okamura H; Nagase S; Noda T; Aiba T; Yasuda S; Shimizu W; Kamakura S; Kusano K
    Europace; 2018 Jun; 20(FI1):f72-f76. PubMed ID: 29036457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.